Two Seas Capital LP - Q2 2022 holdings

$76.8 Million is the total value of Two Seas Capital LP's 8 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 33.3% .

 Value Shares↓ Weighting
HTZZ SellHERTZ GLOBAL HLDGS INC$34,212,000
-60.9%
2,159,856
-45.3%
44.53%
-39.2%
BuyROIVANT SCIENCES LTD$13,919,000
+249.2%
3,419,836
+323.8%
18.12%
+442.4%
RENN BuyRENREN INCsponsored ads$11,500,000
+63.0%
397,655
+23.3%
14.97%
+153.2%
ABUS BuyARBUTUS BIOPHARMA CORP$9,490,000
+44.8%
3,501,876
+59.2%
12.35%
+125.0%
OMEX BuyODYSSEY MARINE EXPL INC$4,193,000
-19.5%
1,229,579
+57.3%
5.46%
+25.1%
AMBC BuyAMBAC FINL GROUP INC$3,047,000
+25.5%
268,457
+15.0%
3.97%
+95.0%
HTZZW SellHERTZ GLOBAL HLDGS INC*w exp 06/30/205$402,000
-48.1%
41,013
-18.7%
0.52%
-19.3%
 ROIVANT SCIENCES LTD*w exp 09/30/202$67,000
-31.6%
111,5090.0%0.09%
+6.1%
ENDP ExitENDO INTL PLC$0-189,543
-100.0%
-0.37%
ExitHERTZ GLOBAL HLDGS INC$0-2,000
-100.0%
-0.55%
SONO ExitSONOS INC$0-81,362
-100.0%
-1.92%
JOBS Exit51JOB INCsponsored ads$0-41,865
-100.0%
-2.05%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HERTZ GLOBAL HLDGS INC8Q3 202379.6%
ROIVANT SCIENCES LTD8Q3 202352.9%
ARBUTUS BIOPHARMA CORP8Q3 202320.8%
ODYSSEY MARINE EXPL INC8Q3 20235.5%
HERTZ GLOBAL HLDGS INC8Q3 20231.0%
AMBAC FINL GROUP INC7Q2 20234.0%
SONOS INC7Q3 20235.1%
ROIVANT SCIENCES LTD7Q2 20231.3%
RENREN INC4Q3 202215.0%
META PLATFORMS INC4Q3 20237.9%

View Two Seas Capital LP's complete holdings history.

Latest filings
TypeFiled
SC 13D/A2024-03-29
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2023-11-21
13F-HR2023-11-14
SC 13G2023-10-05
SC 13D2023-10-02
13F-HR2023-08-14

View Two Seas Capital LP's complete filings history.

Compare quarters

Export Two Seas Capital LP's holdings